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THYROID CANCER AND NODULES
Neck Lymph Nodes in Chronic Autoimmune Thyroiditis:
The Sonographic Pattern
Davide Brancato,1 Roberto Citarrella,2 Pierina Richiusa,2 Marco Calogero Amato,2
Calogero Vetro,2 and Carla Giordano Galluzzo2
Background: Neck lymph nodes may be involved in the pathogenesis of chronic autoimmune thyroiditis (CAT).
This study was undertaken to identify which of the sonographic features of cervical lymph nodes are readily
applicable to patients affected by CAT compared to healthy control subjects.
Methods: We recruited 106 patients (92 females and 14 males) with CAT and 70 control subjects (53 females and
17 males) without clinical, biochemical, and ultrasonographic evidence of thyroid and neck diseases. We per-
formed laboratory tests (thyrotropin, antithyroperoxidase antibodies, antithyroglobulin antibodies, and ultra-
sonography) to evaluate in each group: (i) thyroid function, autoimmunity, and morphology; (ii) number,
topographic distribution (levels I–VI), and morphology of neck nodes (long-axis diameter; short-axis diameter;
short-axis/long-axis ratio; absence or presence of hilus).
Results: Total number of neck nodes with long-axis diameter > 10 mm was significantly higher in the CAT group
than in the control group (mean – standard deviation [SD]: 3.7 – 2.4 vs. 0.8 – 1.3; p < 0.001) with significantly
increased differences in levels II (1.4 – 0.8 vs. 0.3 – 0.5; p < 0.001), III (2 – 1.2 vs. 0.3 – 0.7; p < 0.001), and IV (0.7 – 0.7
vs. 0.07 – 0.2; p < 0.001). More nodes with a hilus were found in the CAT group than in the control group (mean
number of nodes – SD: 2.8 – 1.9 vs. 0.7 – 1.1; p < 0.001). Short-axis diameter of level III (4.4 – 1 vs. 3.7 – 1.2 mm;
p = 0.002) and level IV nodes (3.9 – 1 vs. 3.1 – 0.5 mm p = 0.030) was increased in CAT patients when compared
with healthy controls.
Conclusions: The present study is the first one aiming at a systematic description of the sonographic pattern of
cervical lymph nodes in CAT. An increased number of benign hyperplastic neck nodes, especially in levels II–IV,
appears to be a characteristic sonographic finding associated with CAT.
Introduction
Chronic autoimmune thyroiditis (CAT) is the mostcommon type of thyroiditis and the most frequent cause
of hypothyroidism (1). From a pathological point of view, it is
characterized by various degrees of fibrosis, parenchymal
atrophy, and lymphocytic infiltration. The latter is often ac-
companied by intrathyroidal follicle-like structures contain-
ing germinal centers (2). Both lymphoid follicles within the
thyroid gland and regional lymph nodes may be involved in
the pathogenesis of autoimmune thyroiditis (3–5). In the last
few years, great progress has been made in the understanding
of the pathogenesis of CAT (6,7).
In the context of autoimmune thyroid diseases, ultraso-
nography (US) is a well-established tool to identify patients
with CAT (8), to predict the development of subsequent hy-
pothyroidism (9), to discriminate pseudonodular areas from
suspicious thyroid nodules, and to guide fine-needle aspira-
tion biopsy (10). Moreover, US is able to distinguish two main
forms of CAT: atrophic thyroiditis, characterized by a reduced
thyroid volume and a large number of hyperechoic fibrous
streaks superimposed on a hypoechoic background; and the
most common classical form (Hashimoto’s thyroiditis), char-
acterized by various degrees and heterogeneously distributed
zones of parenchymal hypoechogenicity, with a thyroid vol-
ume ranging from normal-increased to frankly increased (11).
US has also been extensively used to study cervical lymph
nodes in the context of thyroid focal lesions (12) and thyroid
cancer (13), but no systematic study is available to describe the
sonographic pattern of cervical lymph nodes in CAT, despite
the involvement of lymphoid tissue (14).
We hypothesized that the involvement of cervical lymph
nodes in CAT may be associated with a different sonographic
pattern of neck nodes in comparison to subjects without
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thyroid diseases. The knowledge of the characteristic features
of CAT-associated reactive hyperplasia of neck nodes could
be useful for clinicians as an additional element to establish a
diagnosis. The aim of this study was to describe the ultraso-
nographic pattern of cervical lymph nodes in patients affected
by CAT compared to healthy control subjects.
Materials and Methods
Patients
We considered 146 consecutive patients (106 females and
40 males; age range: 15–83 years) with CAT who attended the
thyroid ambulatory at our Institutions during the period be-
tween April 2010 and June 2010 as eligible for the study. All
patients showed a euthyroid state (thyrotropin [TSH] in the
reference range).
All eligible patients underwent clinical examination, in-
cluding neck US, and were evaluated with the following
laboratory tests: TSH, antithyroperoxidase antibodies
(TPOAb), and antithyroglobulin antibodies (TgAb).
Diagnosis of CAT was based upon the presence of paren-
chymal hypoechogenicity (compared to adjacent muscle
structures) for at least one year, in conjunction with elevated
levels of TPOAb and/or TgAb.
We excluded 40 patients who presented the following cri-
teria: occurrence of thyroid nodules or pseudonodular images
on clinical and/or US examination (23 patients); clinical evi-
dence of nonthyroidal benign diseases of the neck and head
(13 patients: 5 patients with recent acute upper respiratory
tract infection; 5 patients with chronic upper respiratory tract
inflammation; 1 patient with Sjo¨gren’s syndrome; 2 patients
with periapical granuloma); a positive history of malignant
diseases (2 patients with Hodgkin’s lymphoma); a positive
history of other autoimmune systemic or other systemic
diseases involving lymphoid tissue (2 patients with lupus
erythematosus). No suspicious neck lymph nodes were found
on clinical examination and/or neck US.
The remaining 106 patients (92 females and 14 males, mean
age 40.5 – 14.8) were included in the study (CAT group). For
each patient included in the study, we recorded the following:
sex; age (expressed in years); duration of disease (expressed
in years after diagnosis); thyroid volume by US (expressed
in mL), calculated using the ellipsoid formula (longitudinal
diameter · transverse diameter · anteroposterior diameter ·
p/6) applied to each lobe; levothyroxine substitution dose
(expressed in lg/day).
As the control group, we selected 70 healthy subjects (53
females and 17 male; age range, 12–87 years; mean age
44.9 – 16) with no clinical, laboratory (TSH, TPOAb, TgAb,
leukocyte count, C-reactive protein, and erythrocyte sedi-
mentation rate), and ultrasonographic evidence of thyroid
diseases or other neck diseases.
Laboratory tests
Laboratory tests were performed both in CAT patients and
the control group. TSH, TPOAb, and TgAb were measured
using chemiluminescence immunometric assays (Immulite
2000; Siemens Medical Solutions Diagnostics, Los Angeles,
CA), with the following reference ranges: TSH = 0.4–4lIU/
mL (analytical sensitivity = 0.004lIU/mL); TPOAb = 0–
35 IU/mL; TgAb = 0–40 IU/mL.
US evaluation
Gray-scale (GSUS) and power Doppler sonography
(PDUS) were performed using an ultrasound mobile system,
the Logiq P5 (General Electric Medical Systems, Milwaukee,
WI), equipped with a wide-bandwidth (range 7–12 MHz)
linear transducer.
All examinations were performed by two examiners with at
least 17 years of experience in thyroid US. GSUS was per-
formed at 12 MHz, and PDUS was performed at 6.7 MHz in
both the CAT and control groups. Standardized Doppler
settings were chosen to optimize detection of the signals from
the lymph node vessels, which had low-velocity flow (pulse-
repetition frequency = 500 Hz; wall filter = 77 or 50 Hz). Re-
presentative images by GSUS were obtained from each lymph
node, so that the maximal area of the node appeared on the
sonograms, with an axial orientation relative to the neck. For
each neck lymph node with a long-axis diameter > 10 mm, we
recorded the following: long-axis diameter (expressed in
mm); short-axis diameter (defined as the widest diameter of
the node in the axial plane perpendicular to the long-axis
diameter; expressed in mm); short-axis diameter/long-axis
diameter ratio (S/L ratio); presence or absence of hilus, de-
fined as a linear, hyperechogenic, nonshadowing structure
containing nodal vessels, and continuous with fat around the
node; location in the neck, classified according to the simpli-
fied level system proposed by Som et al. (15). Briefly, nodes
were assigned to six levels (level I: submental and subman-
dibular nodes; level II: upper internal jugular nodes; level III:
middle jugular nodes; level IV: low jugular nodes; level V:
nodes in the posterior neck triangle; level VI: upper visceral
nodes, between carotid arteries, from the level of the bottom
of the body of the hyoid bone to the level of the top of the
manubrium). Level VII (superior mediastinal nodes) was not
considered, given the scanning limits of GSUS.
Statistical analysis
Continuous variables were shown as mean values–
standard deviation (SD). Rates and proportions were calcu-
lated for categorical data. Differences between the two groups
were analyzed by the Mann–Whitney test (nonparametric test),
as they were continuous variables without normal distribution.
For categorical variables, differences were analyzed with v2 test
and Fisher’s exact test when appropriate. We considered a
p-value < 0.05 significant. We used SPSS v.13 software, Win-
dows Edition (SPSS, Chicago, IL), for all our statistical analysis.
Results
The characteristics of the patients studied and the control
subjects are shown in Table 1. There was no significant dif-
ference between the control and the CAT group in sex, age,
thyroid function (TSH), and thyroid volume. Given the design
of the study, TPOAb and TgAb were significantly higher in
the CAT group ( p< 0.001). The patients in the CAT group had
a mean levothyroxine substitution dose of 83.4 – 36.6 lg/day
and a mean duration of disease of 5.7 – 4.2 years. The total
number of neck nodes with a long-axis diameter > 10 mm was
significantly higher in the CAT group than in the control
group (mean – SD: 3.7 – 2.4 vs. 0.8 – 1.3 mm; p < 0.001) (Table
2). When we analyzed the number of neck nodes subdivided
by level, we found a higher number of neck nodes in the CAT
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group than in the control group for each level analyzed, but
the difference was only statistically significant in level II, III,
and IV nodes (mean – SD: level II 1.4 – 0.8 vs. 0.3 – 0.5 mm,
p < 0.001; level III 2 – 1.2 vs. 0.3 – 0.7 mm, p < 0.001; level IV
0.7 – 0.7 vs. 0.07 – 0.2 mm; p < 0.001) (Table 2). More nodes
with a hilus were found in the CAT group than in the con-
trol group (mean– SD: 2.8 – 1.9 vs. 0.7 – 1.1 mm; p< 0.001)
(Table 2).
The neck node morphology is shown in Table 3. When we
analyzed long-axis and short-axis diameter level by level, we
found significantly higher short-axis diameter in level III and
level IV nodes in the CAT group compared to the control
group (short-axis diameter of III level, mean – SD: 4.4 – 1 vs.
3.7 – 1.2 mm, p= 0.002; short-axis diameter of IV level,
mean – SD: 3.9 – 1 vs. 3.1 – 0.5 mm, p= 0.030). No statistical
difference was found in the S/L ratio. Significantly, we al-
ways found nodes with S/L ratio < 0.5. Figure 1 shows rep-
resentative neck nodes from a CAT patient (Fig. 1A) and one
control subject, respectively (Fig. 1B).
Discussion
Previously, only anecdotal reports about the description of
neck nodes in CAT were available to the medical community.
To the best of our knowledge, the present study is the first one
aiming at providing a systematic description of the sono-
graphic pattern of cervical lymph nodes in CAT.
Until recent years, neck nodes of increased size in CAT
patients were considered as a finding pointing to malignancy
(11). More recently, the extensive use of more refined ultra-
sound equipment has made it possible to understand that the
presence of benign hyperplastic neck lymph nodes is common
Table 2. Number of Neck Nodes (Total and Subdivided
for Each Level), Nodes with Hilus, and Nodes
with Hilus/Total Node Ratio in Chronic
Autoimmune Thyroiditis and Control Groups
Characteristic
CAT group
(n = 106)
(mean – SD)
Control group
(n = 70)
(mean– SD) p
Total number
of neck nodes
3.7 – 2.4 0.8 – 1.3 < 0.001
Nodes with hilus 2.8 – 1.9 0.7 – 1.1 < 0.001
Nodes with hilus/
total nodes ratio
0.7 – 0.3 0.7 – 0.3 NS
Level I nodes 0.06 – 0.2 0.1 – 0.3 NS
Level II nodes 1.4 – 0.8 0.3 – 0.5 < 0.001
Level III nodes 2 – 1.2 1.3 – 1.2 < 0.001
Level IV nodes 0.7 – 0.7 0.07 – 0.2 < 0.001
Level V nodes 0.1 – 0.3 0.06 – 0.2 NS
Level VI nodes 0.8 – 0.3 1.0 – 0.5 NS
Table 3. Long-Axis Diameter (mm), Short-Axis
Diameter (mm), and S/L Ratio of Each Level
Neck Nodes in Chronic Autoimmune
Thyroiditis and Control Groups
US characteristics
CAT group
(n= 106)
(mean –SD)
Control group
(n = 70)
(mean– SD) p
Level I nodes
Long-axis diameter 10.2 – 0.2 11.9 – 2.6 NS
Short-axis diameter 4.1 – 0.8 5.3 – 1 NS
S/L ratio 0.2 – 0.1 0.3 – 0.03 NS
Level II nodes
Long-axis diameter 15.9 – 3.4 14.6 – 2 NS
Short-axis diameter 5.3 – 1.2 5.1 – 0.8 NS
S/L ratio 0.3 – 0.04 0.3 – 0.03 NS
Level III nodes
Long-axis diameter 14 – 2.5 13.2 – 1.5 NS
Short-axis diameter 4.4 – 1 3.7 – 1.2 0.002
S/L ratio 0.2 – 0.05 0.2 – 0.02 NS
Level IV nodes
Long-axis diameter 13.3 – 2.2 11.6 – 1.6 NS
Short-axis diameter 3.9 – 1 3.1 – 0.5 0.030
S/L ratio 0.2 – 0.06 0.2 – 0.06 NS
Level V nodes
Long-axis diameter 12.1 – 1.6 12.9 – 1.4 NS
Short-axis diameter 3.9 – 0.4 4.7 – 0.9 NS
S/L ratio 0.3 – 0.07 0.3 – 0.06 NS
Level VI nodes
Long-axis diameter 14.5 – 1.4 14.5 – 0.7 NS
Short-axis diameter 5.0 – 0.5 5.0 – 0 NS
S/L ratio 0.3 – 0.07 0.3 – 0.06 NS
US, ultrasonography; S/L ratio, short-axis diameter/long-axis
diameter ratio.
Table 1. Clinical and Biochemical Characteristics
of Chronic Autoimmune Thyroiditis
and Control Groups
Characteristic
CAT group
(n = 106)
(mean – SD)
Control group
(n = 70)
(mean– SD) p
Sex (female/male) 92/14 53/17 NS
Age (years; mean – SD) 41.6 – 15.2 44.9 – 16 NS
Thyroid volume (mL) 12.5 – 8.1 11.5 – 2.6 NS
TSH (lUI/mL) 1.6 – 1.2 1.5 – 0.5 NS
TPOAb (UI/mL) 683.8– 815.8 13 – 8.2 < 0.001
TgAb (UI/mL) 475.2– 586.2 11.3 – 9.2 < 0.001
Levothyroxine dose
(lg/day)
83.4 – 36.6 — —
Duration of
disease (years)
5.7 – 4.2 — —
TPOAb, antithyroperoxidase antibodies; TgAb, antithyroglobulin
antibodies; NS, not significant; CAT, chronic autoimmune thyroid-
itis; TSH, thyrotropin; SD, standard deviation.
FIG. 1. Representative example of neck lymph node in one
chronic autoimmune thyroiditis patient (A) compared to
neck lymph node in one control subject (B). Number 1 and
number 2, indicate, respectively, long-axis diameter and
short-axis diameter, with the corresponding dotted line.
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in CAT patients, especially close to the jugular vein and, less
frequently, in the retrothyroid region.
Significantly, we did not find any lymph nodes suggestive
for malignancy in the 106 patients with CAT included in the
analysis (23 patients with CAT and coexistent thyroid nodules
or pseudonodular images were excluded; see Materials and
Methods). Therefore, even if we cannot definitely exclude
other thyroid occult neoplasm in our series, we can assert that
finding neck nodes suggestive for malignancy is infrequent
in CAT.
By contrast, we found an increased number of neck nodes
with long-axis diameter > 10 mm and with benign reactive
features (hilus more frequently present; S/L ratio always
< 0.5). In other autoimmune diseases (i.e., Sjo¨gren’s syndrome
and systemic lupus erythematosus), Ying et al. described an
increased size of cervical neck nodes (16); in a preliminary
study, supraisthmian and/or juxtajugular lymph node en-
largement appeared to be a very useful US sign of subacute
thyroiditis with positive thyroid autoantibodies (17); more-
over, the involvement of cervical lymph node in the patho-
genesis of CAT is well documented (3–5,18,19). Our findings
are consistent with this well-known phenomenon. Further-
more, subdividing the nodes for each level explored, we
found an increased number of neck nodes with long-axis
diameter > 10 mm, which was statistically significant in level
II–IV lymph nodes; moreover, nodes from levels III and IV
showed an increased short-axis diameter. Pathological re-
ports from neck dissections and ultrasonographic studies as-
sessing cervical metastases of patients with papillary thyroid
carcinomas show that levels II, III, and IV are most frequently
involved, revealing that drainage from the thyroid is mainly
from these levels (20,21); this may partially explain our find-
ings, demonstrating a more evident involvement of level III
and IV nodes in CAT patients. We cannot confirm previous
anecdotal reports suggesting a frequent involvement of the
retrothyroid region (22). In five CAT patients, we found one
lymph node each in the retrothyroid region (we excluded a
parathyroid pathology by demonstrating a normal serum
PTH and calcium). Conversely, we did not find any lymph
nodes in the retrothyroid region of control subjects. However,
our numbers (five retrothyroid neck nodes in CAT patients vs.
zero retrothyroid neck nodes in control subjects) are too small
to perform a statistical analysis.
The present study is the first one aiming at a systematic
description of the sonographic pattern of cervical lymph
nodes in CAT. We conclude that an increased number of be-
nign hyperplastic neck nodes, especially in levels II, III, and
IV, appears to be a characteristic sonographic finding associ-
ated with CAT.
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